Application of a nasopharyngeal airway in the recovery anaesthesia period of obese patients undergoing deep neuromuscular blockade endoscopic surgery

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200066179

Enrollment

Unknown

Registered

2022-11-26

Start date

2022-11-26

Completion date

Unknown

Last updated

2023-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypoxemia

Interventions

Experimental group 1:nasopharyngeal airway

Experimental group 2:Oropharyngeal airway

Control group:Mask oxygen inhalation

Eligibility

Sex/Gender

All

Age

20 Years to 70 Years

Inclusion criteria

Inclusion criteria: ASAI-III; BMI >= 28 kg/m^2; age 20-70 years; sex not restricted; Endoscopic surgery

Exclusion criteria

Exclusion criteria: Diseases of the neuromuscular system; severe dysfunction of vital organs (lung, liver, kidney); nasal and oral and maxillofacial deformities, obstruction, surgery, etc.; history of bleeding disorders, coagulation disorders, etc.

Design outcomes

Primary

Measure	Time frame
Arterial blood carbon dioxide partial pressure;	—

Secondary

Measure	Time frame
Blood oxygen saturation;Nausea and vomiting, choking and coughing, restlessness;Number of secondary placements;	—

Countries

China

Contacts

Public ContactXiaoqiong Xia

Chaohu Hospital of Anhui Medical University

xxq2366833@sina.com+86 139 6638 6669

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026